000 05014cam a2200409Ii 4500
001 95322
003 ES-MaUEC
005 20230102112658.0
006 m o d
007 cr cnu|||unuuu
008 170206s2017 sz of 000 0 eng d
020 _a3319406280
_q(electronic bk.)
020 _a9783319406282
_q(electronic bk.)
020 _z3319406264
020 _z9783319406268
_q(print)
035 _a(OCoLC)971492041
_z(OCoLC)971593757
_z(OCoLC)971949017
_z(OCoLC)972102268
_z(OCoLC)972204257
_z(OCoLC)972461866
_z(OCoLC)972537225
_z(OCoLC)981868957
_z(OCoLC)1005757899
_z(OCoLC)1011796666
040 _aN$T
_cN$T
_dEBLCP
_dGW5XE
_dN$T
_dIDEBK
_dYDX
_dOCLCF
_dNJR
_dCOO
_dAZU
_dVT2
_dUPM
_dZ5A
_dJBG
_dIAD
_dICW
_dICN
_dOCLCQ
_dMERUC
_dUAB
_dES-MaUEC
_bspa
050 4 _aRC377
_b2017 EB
245 0 0 _aHandbook of relapsing-remitting multiple sclerosis
_cAaron Miller, editor.
264 1 _aCham, Switzerland
_bAdis
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPreface; Contents; Contributors; Chapter 1: Multiple Sclerosis: An Overview; 1.1 Introduction; 1.2 Epidemiology and Risk Factors; References; Chapter 2: The Pathophysiology and Clinical Presentation of Multiple Sclerosis; 2.1 Introduction; 2.2 Etiology of Multiple Sclerosis; 2.2.1 Autoimmunity; 2.2.2 Genetics; 2.2.3 Infectious; 2.2.4 Degenerative; 2.3 Pathophysiologic Mechanisms of Multiple Sclerosis; 2.4 White Matter Plaque Formation; 2.5 Blood-Brain Barrier Breakdown, Leukocyte Entry, Demyelination, and Axonal Injury; 2.6 Cortical Demyelination.
505 8 _a2.7 Diffuse White Matter Changes, Global Atrophy, and Progressive Degeneration2.8 Remyelination and Repair; 2.9 The Clinical Presentation of Multiple Sclerosis; 2.10 Common Symptoms; 2.10.1 Fatigue; 2.10.2 Cognitive Dysfunction; 2.10.3 Mood Symptoms; 2.10.4 Optic Neuritis; 2.10.5 Brainstem and Cerebellar Symptoms; 2.10.6 Sensory Disturbances; 2.10.7 Motor Symptoms; 2.10.8 Bladder, Bowel, and Sexual Dysfunction; 2.11 Conclusion; References; Chapter 3: Assessment and Diagnosis of Relapsing Multiple Sclerosis; 3.1 Introduction.
505 8 _a3.2 Patient History and Clinical Relapses in Establishing a Diagnosis3.3 Role of MRI in Establishing a Diagnosis; 3.4 Patients Who Do Not Meet Full Diagnostic Criteria: Clinically Isolated Syndrome and Radiologically Isolated Syndrome; 3.4.1 Clinically Isolated Syndrome; 3.4.2 Radiologically Isolated Syndrome; 3.5 Role of Ancillary Testing in Establishing a Diagnosis (CSF Analysis and Evoked Potentials); 3.6 Assessment Scales; 3.7 Patient Counseling and Education; 3.8 Differential Diagnosis; 3.9 Neuromyelitis Optica Spectrum Disorders; 3.10 Acute Disseminated Encephalomyelitis; References.
505 8 _a5.2 New Monoclonal Antibodies5.2.1 Daclizumab; 5.2.2 Ocrelizumab; 5.3 Remyelination and Repair; 5.3.1 Anti-LINGO-1; 5.4 Stem Cell Therapeutics; 5.4.1 Hematopoietic Stem Cell Transplantation; 5.4.2 Mesenchymal Stem Cell Transplantation; Intravenous Mesenchymal Stem Cell Application; Intrathecal Mesenchymal Stem Cell Application; 5.4.3 Glial Progenitor Cell Transplantation; References; Chapter 6: Symptom Management in Multiple Sclerosis; 6.1 Introduction; 6.2 Fatigue; 6.3 Sensory Deficits and Pain; 6.4 Motor and Balance Issues; 6.5 Visual Deficits; 6.6 Bladder, Bowel, and Sexual Issues.
505 8 _aChapter 4: Treatment Strategies in Multiple Sclerosis4.1 Introduction; 4.2 Initiating Therapy; 4.3 Disease-Modifying Therapies; 4.3.1 Interferons; 4.3.2 Glatiramer Acetate; 4.3.3 Natalizumab; 4.3.4 Fingolimod; 4.3.5 Teriflunomide; 4.3.6 Dimethyl Fumarate; 4.3.7 Alemtuzumab; 4.3.8 Mitoxantrone; 4.4 Switching Disease-Modifying Therapies; 4.5 Acute Treatment of Relapses; 4.6 Treatment of Multiple Sclerosis During Pregnancy; 4.7 Treatment of Pediatric Multiple Sclerosis; 4.8 Conclusion; References; Chapter 5: Emerging Therapies in Multiple Sclerosis; 5.1 Introduction.
520 3 _aThis pocketbook is an evidence-based educational resource that provides a concise overview of diagnosis, treatment and long-term management of relapsing-remitting multiple sclerosis. An ideal clinical handbook for a wide range of medical professionals, this handbook includes international guidelines, clinically relevant clinical trial data, and an introduction to emerging therapies. Handbook of Relapsing-Remitting Multiple Sclerosis is a comprehensive overview of recent advances in this indication, enhanced by high quality figures and clinical images.
650 7 _aEsclerosis múltiple
_2embne
_0(OCoLC)fst01029018
_0
_9142007
700 1 _aMiller, Aaron E.,
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-40628-2
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c95322
_d95322
_x1